There were only four species of Plasmodium that were thought to cause malaria in humans until a large number of human infections by Plasmodium knowlesi, a malaria parasite typically found in long-tailed and pig-tailed macaques, were reported in 2004 in Malaysian Borneo. Since then, cases of knowlesi malaria have been reported throughout South-east Asia and also in travellers returning from the region. This article describes the molecular, entomological and epidemiological data which indicate that P. knowlesi is an ancient parasite that is primarily zoonotic, and there are three highly divergent sub-populations. It also describes the detection methods for P. knowlesi, which is morphologicaly similar to P. malariae, and the clinical features and treatment of this malaria parasite that is potentially fatal.
. The study in Kapit was prompted by observations that cases diagnosed by microscopy as P. malariae had high parasitaemias, required hospitalization and that 95% of patients were adults. This was in contrast to P. malariae infections which typically are asymptomatic with low parasitaemia and occur in all age groups. When blood samples from 208 malaria patients at Kapit Hospital were analysed by PCR assays, none were identified as P. malariae, although 141 had been diagnosed as P. malariae by microscopy. Fifty-eight percent (120) were either single P. knowlesi infections or mixed infections of P. knowlesi with P. falciparum and P. vivax. Misdiagnosis had occurred because the blood stages of P. knowlesi and P. malariae are morphologically indistinguishable 3 .
Epidemiology and risk factors of acquiring knowlesi malaria
Human infections with P. knowlesi have been reported throughout Malaysia and in Thailand, Singapore, the Philippines, Vietnam, Cambodia, Indonesia, Brunei, Myanmar and in the Nicobar and Andaman Islands of India 4, 5 . In Malaysia, P. falciparum and P. vivax cases have declined over the past five years and P. knowlesi has now become the most common cause of human malaria 6, 7 . The true incidence of knowlesi malaria is not known in other parts of Southeast Asia since not many large-scale studies have been undertaken with molecular detection assays.
The geographical distribution of human P. knowlesi infections is similar to that of the natural hosts of P. knowlesi, the long-tailed and pig-tailed macaques 8 . 
Molecular and whole genome studies
In order to understand the molecular epidemiology and demographic history of knowlesi malaria, the mitochondrial (mt) genome sequences of P. knowlesi were initially studied 17 . Certain mt haplotypes were shared between humans and macaques and there were no haplotypes that were associated exclusively with either host; further evidence supporting P. knowlesi as a zoonotic parasite.
Additional analyses indicated that P. knowlesi was as old as, if not older than, P. falciparum and P. vivax, and that it underwent a population expansion between 30,000 to 40,000 years ago. Macaques colonized Asia over 5 million years ago 18 and are probably the 
Diagnosis
In laboratories in malaria-endemic countries, malaria is diagnosed by examination of blood films by microscopy. Under the microscope, the early blood forms of P. knowlesi are identical to those of P. falciparum, while the other developmental stages, including the 'band forms', are similar to those of P. malariae 3 . There are minor morphological differences between these two species. Clinical and laboratory features of knowlesi malaria P. knowlesi causes a wide spectrum of disease, from asymptomatic infections 9,25 to fatal ones [26] [27] [28] [29] . The most common presenting signs and symptoms reported are fever with chills, followed by headache, myalgia, poor appetite, arthralgia, cough, abdominal pain and diarrhoea 27 . These are not significantly different to those observed in patients with vivax and falciparum malaria. The majority of cases (93.5% 27 and 84.5% 30 ) at district hospitals in Sarawak had uncomplicated malaria with a fatality rate of 2%, whereas in a retrospective study in a referral hospital in Sabah, 61% of 56 cases were uncomplicated and the fatality rate was 27% 31 . However, subsequently at the same referral hospital, the use of intravenous artesunate for severe malaria cases and artemisinin combination therapy for nonsevere cases, resulted in no deaths among 130 knowlesi malaria patients 29 . Typical complications of severe knowlesi malaria in adults include jaundice, acute kidney injury, hypotension, acute respiratory distress syndrome and metabolic acidosis 26, 27, 29, 30, 32 . In adults, severe anaemia has not been observed and neither has cerebral malaria, while severe disease has not been noted in the relatively small number of children with knowlesi malaria 4, 33 .
Thrombocytopaenia is very common, occurring in 97.3 to 100% of knowlesi malaria patients, and together with parasitaemia, correlates with severity of disease 27, 30, 31 . Following a case control study, it was recommended that any patient with a platelet count of <45 000/mL or parasitaemia of >35 000 parasites/mL should be regarded at risk of developing complications and should be treated for severe malaria 30 .
Under the Microscope
Treatment of knowlesi malaria
Since knowlesi malaria is primarily a zoonosis, the parasites have been under no antimalarial drug pressure and should be susceptible to all antimalarials. This has been observed in hospital-based studies as well as case reports where several antimalarials have been used successfully to treat knowlesi malaria patients 4 . P. knowlesi parasites are highly sensitive to chloroquine 34 but following an informal consultation on the public health importance of knowlesi malaria organised by the WHO in 2011, it was recommended that in areas where knowlesi malaria has been detected, all infections diagnosed as P. malariae by microscopy should be treated and managed as for falciparum malaria 35 . Therefore, for uncomplicated knowlesi malaria cases in South-east Asia, artemisinin combination therapy is recommended. For severe knowlesi malaria, intravenous antimalarials should be administered and the use of artesunate in a tertiary referral hospital in Sabah was associated with zero mortality 29 .
Future directions
The available molecular, entomological and epidemiological data strongly indicate that knowlesi malaria is primarily a zoonosis.
However, human-to-human transmission has been demonstrated under experimental conditions 9 and it is not known whether it is currently occurring. The reasons for the increase in the number of knowlesi malaria cases, particularly in Malaysian Borneo, are also unknown. Whether the increase is due to increased awareness, changes in the feeding habits of the vectors, the destruction of the natural habitats of the macaque reservoir, human migration to areas close to macaque habitats, a recent adaptation of knowlesi malaria parasites to humans, or to some other factors needs to be investigated. In addition, currently available methods of control of human malaria involving the use of insecticide treated bednets and residual spraying of houses are ineffective against knowlesi malaria, where transmission primarily occurs outdoors. Therefore, effective methods of prevention and control need to be found and implemented, in order to prevent P. knowlesi from establishing itself in the human population.
